arrow
S

Séamus Hussey

University of British Columbia
H指数:32
被引数:5,822

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of Pediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update

儿科克罗恩病的治疗:ECCO-ESPGHAN指南更新

2026-08-190
OAAI
Transitioning to adult care for patients with IBD: the impact of a structured IBD transition program on service engagement

炎症性肠病患者向成人医疗过渡:结构化炎症性肠病过渡项目对服务参与度的影响

2026-04-110
PRE
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration

更正:10岁及以下儿童炎症性肠病患者的英夫利昔单抗群体药代动力学分析:标签推荐剂量未能达到治疗靶浓度

2025-11-280
OAAI
Chronic nonbacterial osteomyelitis associated with pediatric inflammatory bowel disease: A multicenter retrospective study from the Paediatric IBD Porto Group of ESPGHAN

与儿童炎症性肠病相关的慢性非细菌性骨髓炎:一项来自ESPGHAN儿科IBD波尔图组的 multicenter retrospective study。

2025-11-010
PRE
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration

10岁以下儿童炎症性肠病患者的英夫利昔单抗群体药代动力学分析:标签推荐剂量无法达到治疗靶浓度

2025-10-290
OA
De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease

中性粒细胞亚群中从头DUOX2表达塑造肠道疾病的发病机制

2025-05-060
OA
Modified Crohn’s Disease Exclusion Diet Maintains Remission in Pediatric Crohn’s Disease: Randomized Controlled Trial

改良型克罗恩病排除饮食维持儿科克罗恩病缓解:随机对照试验

2024-12-260
PREAI
Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN

溃疡性直肠炎儿科患者的临床特征和自然史: ESPGHAN儿科IBD Porto小组的多中心研究

2023-07-014
PRE